Welcome to Allen & Overy’s Investigations Insight blog, sharing with you our views and insights into the latest trends, risks and developments in business crime and financial services investigations
eDiscovery in investigations: Collecting evidence efficiently and defensibly
12 January 2021 - Post by:
The collection and review of data can be a large, important and potentially costly part of a corporate investigation. In this blog post, which is the first in a short series on eDiscovery, we will look at how to make data collection and review as effective and painless as possible, whilst at the same time › Read More
10 November 2020 - Post by:
The SFO has concluded a deferred prosecution agreement with Airline Services Limited (ASL), a UK supplier of aircraft cabin parts and services, for failure to prevent bribery under s7 Bribery Act 2010. Despite the company having received external legal advice on ABAC policies and procedures, it had failed to implement the recommendations adequately: Serious Fraud › Read More
SFO releases guidance on deferred prosecution agreements
06 November 2020 - Post by:
On 23 October 2020, the SFO published another chapter of its gradually evolving Operational Handbook (the Handbook), this time covering the invariably attention-grabbing topic of Deferred Prosecution Agreements (DPAs). This newest addition to the Handbook, which follows and complements last year’s chapter on corporate co-operation, may not present those who are familiar with the SFO’s › Read More
Legal resilience: lessons learnt from recent crises
29 October 2020 - Post by:
Back in March, many of my colleagues were fielding urgent and complex Covid-related legal queries. Many of the questions were familiar to those who remembered other recent crises, and caused us to think about what organisations could learn about legal resilience, including around dealing with regulators and compliance issues. This has resulted in A&O’s very › Read More
Listing applications by cannabis companies – FCA statement
21 October 2020 - Post by:
The FCA has clarified its approach to applications to list in the UK made by cannabis-related companies. The statement acknowledges the uncertainty surrounding cannabis-related ventures from a money laundering perspective, given the distinction between recreational cannabis companies and those operating in the medical space. Those in the former category are prevented from listing in the › Read More